These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 8519449)

  • 1. Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication.
    Angel JB; Saget BM; Walsh SP; Greten TF; Dinarello CA; Skolnik PR; Endres S
    AIDS; 1995 Oct; 9(10):1137-44. PubMed ID: 8519449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: involvement of NF-kappaB and NFAT.
    Navarro J; Punzón C; Jiménez JL; Fernández-Cruz E; Pizarro A; Fresno M; Muñoz-Fernández MA
    J Virol; 1998 Jun; 72(6):4712-20. PubMed ID: 9573235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble tumor necrosis factor receptors inhibit phorbol myristate acetate and cytokine-induced HIV-1 expression chronically infected U1 cells.
    Granowitz EV; Saget BM; Angel JB; Wang MZ; Wang A; Dinarello CA; Skolnik PR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):430-7. PubMed ID: 8605587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-10 enhances human immunodeficiency virus type 1 expression in a chronically infected promonocytic cell line (U1) by a tumor necrosis factor alpha-independent mechanism.
    Angel JB; Saget BM; Wang MZ; Wang A; Dinarello CA; Skolnik PR
    J Interferon Cytokine Res; 1995 Jun; 15(6):575-84. PubMed ID: 7553227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids.
    Sinha B; Semmler J; Eisenhut T; Eigler A; Endres S
    Eur J Immunol; 1995 Jan; 25(1):147-53. PubMed ID: 7843225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor.
    Prabhakar U; Lipshutz D; Bartus JO; Slivjak MJ; Smith EF; Lee JC; Esser KM
    Int J Immunopharmacol; 1994 Oct; 16(10):805-16. PubMed ID: 7843852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylarsine oxide inhibits ex vivo HIV-1 expression.
    Arbault S; Edeas M; Legrand-Poels S; Sojic N; Amatore C; Piette J; Best-Belpomme M; Lindenbaum A; Vuillaume M
    Biomed Pharmacother; 1997; 51(10):430-8. PubMed ID: 9863501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer.
    Souness JE; Griffin M; Maslen C; Ebsworth K; Scott LC; Pollock K; Palfreyman MN; Karlsson JA
    Br J Pharmacol; 1996 Jun; 118(3):649-58. PubMed ID: 8762090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of tumor necrosis factor-alpha production by interleukin-10 is enhanced by cAMP-elevating agents.
    Siegmund B; Eigler A; Moeller J; Greten TF; Hartmann G; Endres S
    Eur J Pharmacol; 1997 Feb; 321(2):231-9. PubMed ID: 9063693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells.
    Semmler J; Wachtel H; Endres S
    Int J Immunopharmacol; 1993 Apr; 15(3):409-13. PubMed ID: 8505151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
    Seldon PM; Barnes PJ; Meja K; Giembycz MA
    Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism.
    Peterson PK; Gekker G; Chao CC; Hu SX; Edelman C; Balfour HH; Verhoef J
    J Clin Invest; 1992 Feb; 89(2):574-80. PubMed ID: 1310698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
    Granowitz EV; Saget BM; Wang MZ; Dinarello CA; Skolnik PR
    Mol Med; 1995 Sep; 1(6):667-77. PubMed ID: 8529133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells.
    Okamoto M; Ono M; Baba M
    AIDS Res Hum Retroviruses; 1998 Sep; 14(14):1239-45. PubMed ID: 9764907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro.
    La Maestra L; Zaninoni A; Marriott JB; Lazzarin A; Dalgleish AG; Barcellini W
    Clin Exp Immunol; 2000 Jan; 119(1):123-9. PubMed ID: 10606973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentoxifylline inhibits acute HIV-1 replication in human T cells by a mechanism not involving inhibition of tumour necrosis factor synthesis or nuclear factor-kappa B activation.
    Navarro J; Punzón MC; Pizarro A; Fernández-Cruz E; Fresno M; Muñoz-Fernández MA
    AIDS; 1996 May; 10(5):469-75. PubMed ID: 8724037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The specific type IV phosphodiesterase inhibitor rolipram combined with adenosine reduces tumor necrosis factor-alpha-primed neutrophil oxidative activity.
    Sullivan GW; Carper HT; Mandell GL
    Int J Immunopharmacol; 1995 Oct; 17(10):793-803. PubMed ID: 8707444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cicaprost and the type IV phosphodiesterase inhibitor, rolipram, synergize in suppression of tumor necrosis factor-alpha synthesis.
    Greten TF; Sinha B; Haslberger C; Eigler A; Endres S
    Eur J Pharmacol; 1996 Mar; 299(1-3):229-33. PubMed ID: 8901027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice.
    Liang L; Beshay E; Prud'homme GJ
    Diabetes; 1998 Apr; 47(4):570-5. PubMed ID: 9568689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.